Novo Nordisk’s chief executive has signalled openness to listing the Danish drugmaker’s shares directly on the New York Stock Exchange. CEO Doustdar told a newspaper that he sees clear advantages in pursuing
Nevada’s Supreme Court has overturned a key piece of caselaw governing how contingency fee attorneys’ fees are awarded following successful offers of judgment. The ruling, handed down in Clark v. Marin on
More
Legal professionals face mounting pressure to adopt artificial intelligence tools, with negligence claims now a potential consequence of failing to do so in practice. The question of whether a lawyer can be
More
Global equity markets came under pressure as rising geopolitical tensions involving Iran rattled investor sentiment across major US indices on Wednesday. The S&P 500 and Nasdaq Composite both recorded losses as traders
More
Investors searching for income are increasingly turning to FTSE 250 stocks as Cash ISA rates continue to disappoint savers across the United Kingdom. One particular FTSE 250 stock has drawn attention for
More
Hengrui Pharma and Elevar Therapeutics have received a third complete response letter from the FDA for their camrelizumab and rivoceranib combination therapy. The rejection marks more than two years of regulatory setbacks
More
The Supreme Court’s June 25, 2026, decision in Monsanto Company v. Durnell marks the most significant interpretation of FIFRA’s preemption provision since the earlier Bates v. Dow Agrosciences ruling. The landmark ruling
More
The Supreme Court’s October Term 2025 delivered consequential rulings for environmental law, even though environmental cases were not the central focus of the merits docket. The Court’s decisions addressed foundational issues including
More
London equities managed modest gains on Monday as rising oil prices lifted energy stocks, helping the market absorb fresh geopolitical shock from renewed U.S. military action against Iran. The FTSE 100 rose
More
Greggs (GRG) has been a frustrating holding for many retail investors, with shares underperforming expectations over a prolonged period. The British bakery chain, once celebrated as one of the UK stock market’s
More
BioMarin has launched a three-episode video podcast series called “Why Do I Pheel This Way?” aimed at teens living with phenylketonuria, known as PKU. The campaign centres on real conversations about the
More